1 December 2023
Ropes & Gray Advises Avidity Biosciences in Expanded Cardiovascular Global Licensing Collaboration with Bristol Myers Squibb
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David McIntosh | Ropes & Gray | Partner | life sciences transactions | Not stated |
| Thomas Danielski | Ropes & Gray | Partner | capital markets | Not stated |
| David Saltzman | Ropes & Gray | Partner | tax | Not stated |
| Nicole Rohr | Ropes & Gray | Associate | life sciences transactions | Not stated |
| Corrine Maguire | Ropes & Gray | Associate | life sciences transactions | Not stated |
| Rachel Lehman | Ropes & Gray | Associate | capital markets | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 2.30bn ($2.3 billion)
- What the figure measures
- Total transaction value
- Client
- Avidity BiosciencesOther
- Counterparties
- Bristol Myers Squibb (Other)